Host William Lou recaps the Toronto Raptors' 113-103 loss to the Oklahoma City Thunder.
Host William Lou recaps the Toronto Raptors' 113-103 loss to the Oklahoma City Thunder.
It comes more than 20 years after he found fame in Castaway 2000.
FRANKFURT — German Chancellor Angela Merkel has defended her lobbying for Wirecard during a 2019 visit to China, testifying before a parliamentary committee Friday that the payments company received no special treatment and that it was in Germany's interest to promote its businesses. Merkel said Wirecard's aim of entering the Chinese market overlapped with the best interests of the German economy as a whole. The company later collapsed in an accounting scandal. “Despite all the press reports, there was no reason to assume serious irregularities at Wirecard” at the time of the China trip, German news agency dpa quoted the chancellor as telling the committee. Wirecard filed for protection from creditors through insolvency proceedings in June after admitting that 1.9 billion euros ($2.3 billion) supposedly held in trust accounts in the Philippines probably didn’t exist. Some German lawmakers have accused authorities — from financial supervisors to prosecutors and auditors — of looking the other way, despite reports of irregularities at Wirecard dating back at least five years. The committee is investigating. Asked about a meeting ahead of the China visit with Karl-Theodor zu Guttenberg, a former defence minister whose firm advised Wirecard, Merkel said she could not remember if Guttenberg had specifically named Wirecard. Prosecutors in Munich are investigating the company's former chief executive, Markus Braun, on suspicion of criminal fraud. Finance Minister Olaf Scholz appeared by the committee on Thursday. Scholz denied any responsibility on his or the government's part for failures of oversight. He also rejected suggestions that German regulators or the Finance Ministry, which oversees them, protected Wirecard. But he conceded that the regulatory structure had not been set up well enough for such a case. Scholz is also Germany's vice chancellor and his Social Democratic Party's candidate for chancellor in the country's Sept. 26 national election. Merkel is not running again and plans to leave office after almost 16 years as chancellor. The Associated Press
Andre Brady loved his job as a sales manager at the Youngstown State University bookstore. “The bottom line is you’re always going to need a university bookstore,” Brady, 44, said in an interview. To say that Brady fought his job loss is an understatement.
SAN FRANCISCO, April 23, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Ebix, Inc. (NASDAQ: EBIX) investors with significant losses to submit your losses now. A securities fraud class action has been filed and certain investors may have valuable claims. Class Period: Nov. 9, 2020 – Feb. 19, 2021Lead Plaintiff Deadline: April 23, 2021Visit: www.hbsslaw.com/cases/EBIXContact An Attorney Now: EBIX@hbsslaw.com 844-916-0895 Ebix, Inc. (EBIX) Securities Fraud Class Action: The complaint alleges that Defendants concealed that: (1) there was insufficient audit evidence to determine the business purpose of certain significant unusual transactions in Ebix’s gift card business in India during 4Q 2020; (2) that there was a material weakness in Company’s internal controls over the gift or prepaid revenue transaction cycle; and (3) that the Company’s independent auditor, RSM, was reasonably likely to resign over disagreements with Ebix regarding $30 million that had been transferred into a commingled trust account of Ebix’s outside legal counsel. Investors began to learn the truth on Feb. 19, 2021 when RSM abruptly resigned, stating that that “despite repeated inquiries” RSM was unable to obtain sufficient audit evidence to “evaluate the business purpose of significant unusual transactions that occurred in the fourth quarter of 2020, including whether such transactions have been properly accounted for and disclosed in the financial statements subject to the Audit.” These “unusual transactions” concerned the company’s gift card business in India. In addition, RSM and Ebix reportedly disagreed over whether $30 million transferred to a comingled trust account of Ebix’s outside counsel should still be classified as cash on Ebix’s balance sheet, even though those funds were outside Ebix’s direct control. On this news, the Company’s share price fell as much as $20.24, or 40%, in a single trading day. On Mar. 8, 2021, Ebix announced it has retained KG Somani & Co. as its new auditor, that it would not file its annual report until Apr. 2021, and that Board-appointed consultants and outside legal counsel are continuing “to evaluate the payment solutions business.” Most recently, on Mar. 11, 2021, the Company received a noncompliance letter from Nasdaq for failing to timely file its 10-K, demanding that EBIX submit a plan to regain compliance with Nasdaq’s rules by Apr. 16. “We’re focused on investors’ losses and proving Ebix insiders cooked the company’s books,” said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in Ebix shares and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman. Whistleblowers: Persons with non-public information regarding Ebix should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email EBIX@hbsslaw.com. About Hagens BermanHagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw. Contact: Reed Kathrein, 844-916-0895
Manulife Investment Management today announced the April 2021 cash distributions for Manulife Exchange Traded Funds (ETFs) that distribute monthly. Unitholders of record of the Manulife ETFs at the close of business on April 30, 2021 will receive cash distributions payable on May 13, 2021. The ex-dividend date for the cash distributions is April 29, 2021.
The "2021 World Immunodiagnostics Market Assessment of 97 Countries-Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer Diagnostic, Endocrine, Immunoprotein, TDM, and Special Chemistry Tests" report has been added to ResearchAndMarkets.com's offering.
The growth of the CNC controller market is majorly driven by rising adoption of industrial automation in manufacturing industries and increasing demand for mass production across automotive industry,New York, April 23, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "CNC Controller Market with COVID-19 Impact by Offering, Machine Type, Axis Type, Sales Channel, Industry And Region - Global Forecast to 2026" - https://www.reportlinker.com/p04975550/?utm_source=GNW COVID-19 has emerged as a global pandemic that has spread in several countries worldwide and disrupted various industries around the world.The prominent players across industries have been affected by this pandemic.The foreseeable decline in the growth of end-user applications may have a considerable direct impact on the CNC controller market.Indirect sales channels expected to grow at highest CAGR during the forecast period.Manufacturers majorly provide CNC controllers to end users through indirect sales channels or third-party providers.Most key players in the market have well-established sales networks and distribute their products worldwide.End users may lack the expertise required to integrate CNC controllers into CNC machines; thus, installations are majorly undertaken by system integrators or third-party providers appointed by companies. Owing to these factors, the indirect sales channel segment is projected to grow at a higher CAGR during the forecast period.Automotive industry is expected to contribute largest share of market during the forecast period.The automotive segment is estimated to account for the largest share of the market in 2021.To ensure enhanced power consumption and safety, modern automobile manufacturers adopt IoT and V2X communication technologies which enable vehicles to communicate with smart traffic signals.Thus, such advancements in automotive manufacturing technologies and increasing investments by key automotive manufacturers are some of the factors expected to drive the growth of the market in the automotive industry during the forecast period.APAC is expected to contribute the largest share of market during the forecast period.APAC is estimated to account for the largest share of the CNC controller market in 2021.Growth of the market is majorly driven by the growing manufacturing sector in the region.Continuous advancements and technological innovations in various industries; economic development in major economies such as China, Japan, and India; increasing infrastructural developments in Southeast Asian countries such as Singapore, Thailand, and Malaysia, among others; and rising foreign investments in this region is expected to fuel market growth.Break-up of the profiles of primary participants:• By Company Type – Tier 1 – 40%, Tier 2 – 35%, and Tier 3 – 25%• By Designation – C-level Executives – 55%, Directors – 35%, and Others – 10%• By Region – North America - 35%, Europe – 30%, APAC – 25%, and RoW – 10%FANUC(Japan), Siemens(Germany), Mitsubishi Electric(Japan), DMG MORI(Japan), Haas Automation(US), Hurco Companies(US), and Okuma(Japan) among others, are some of the key players in the market.The CNC Controller market has been segmented into offering, machine type, axis type, sales channel, industry, and region. The CNC controller market has been studied for North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW).Reasons to buy the report:• Illustrative segmentation, analysis, and forecast of the market based on offering, machine type, axis type, sales channel, industry, and region have been conducted to give an overall view of the CNC controller market.• A value chain analysis has been performed to provide in-depth insights into the CNC controller market ecosystem.• The report includes pricing analysis, patent analysis, ecosystem analysis as well as technology, trade and case study analysis pertaining to CNC controller.• The key drivers, restraints, opportunities, and challenges pertaining to the CNC controller market have been detailed in this report.• Detailed information regarding the COVID-19 impact and related updates on the CNC controller market has been provided in the report.• The report includes a detailed competitive landscape of the market, along with key players, as well as in-depth analysis of their revenues and market share.Read the full report: https://www.reportlinker.com/p04975550/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Yellow Pages Limited (TSX: Y) (the "Company"), a leading Canadian digital media and marketing company, announces the full redemption on May 31, 2021 of the aggregate principal amount, equal to $107,033,000, of its Exchangeable Debentures.
WILMINGTON, Del., April 23, 2021 (GLOBE NEWSWIRE) -- Ashland Global Holdings Inc. (NYSE: ASH) will issue its second-quarter earnings release at approximately 5 p.m. ET on Wednesday, April 28, 2021. The company’s live webcast with securities analysts and investors will take place at 10 a.m. ET, Thursday, April 29, 2021 and include an executive summary and detailed remarks. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chairman and chief executive officer;Kevin Willis, senior vice president and chief financial officer; andSeth Mrozek, director of investor relations. The webcast and supporting materials will be accessible through the Investor Relations section of the Ashland website at http://investor.ashland.com. Following the live event, an archived version of the webcast and supporting materials will be available on the website for 12 months. About Ashland Ashland Global Holdings Inc. (NYSE: ASH) is a premier specialty materials company with a conscious and proactive mindset for sustainability. The company serves customers in a wide range of consumer and industrial markets, including adhesives, architectural coatings, automotive, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceutical. Approximately 4,200 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit www.ashland.com and www.ashland.com/sustainability to learn more. ™ Trademark, Ashland or its subsidiaries, registered in various countries. FOR FURTHER INFORMATION: Investor Relations: Media Relations:Seth A. Mrozek Carolmarie C. Brown+1 (302) 594-5010 +1 (302) email@example.com firstname.lastname@example.org Attachment Ashland to report financial results for second quarter fiscal 2021 2021422
MONTREAL, April 23, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight") a pan-America (ex-USA) specialty pharmaceutical company, today announced that it has entered into a definitive agreement under which Knight will acquire the exclusive rights to manufacture, market and sell Exelon® (rivastigmine Patch, Capsules and Solution) in Canada and Latin America (the “Territory”), as well as an exclusive license to use the intellectual property and the Exelon trademark, from Novartis within the Territory. Exelon (rivastigmine) is a prescription product that was first approved in 1997 and is currently registered and sold in approximately 90 countries. Exelon is indicated for the symptomatic treatment of mild to moderately severe dementia in people with Alzheimer’s disease. At closing, Knight will pay USD $168 million in cash and an additional milestone payment of up to USD $12 million upon the achievement of certain conditions. Exelon had annual revenues for 2020 of approximately 47 Million US dollars for Canada and Latin America. “We are excited to add Exelon to our portfolio of specialty CNS products and continue to support this well established and important therapy option in an area of such high unmet need as Alzheimer’s”, said Samira Sakhia, President and Chief Operating Officer of Knight. “The acquisition of Exelon leverages Knight’s pan-American (ex-US) platform and further validates our Rest-of-world strategy”, said Amal Khouri, Chief Business Officer of Knight. “Exelon will be the first product that we will be selling across our entire territory”. The closing of this transaction is subject to anti-trust clearance in Brazil. In conjunction with closing, Knight will enter into a transition service agreement until transfer of marketing authorization, on a country by country basis during which Knight will receive a net profit transfer. Knight will begin distributing Exelon upon transfer of marketing authorization, on a country by country basis. Conference Call Notice Knight will host a conference call and audio webcast to discuss the Exelon acquisition today at 8:30 am ET. Knight cordially invites all interested parties to participate in this call. Date: Friday, April 23, 2021Time: 8:30 a.m. ETTelephone: Toll Free 888-506-0062 or International 973-528-0011Webcast: www.gud-knight.com or WebcastThis is a listen-only audio webcast. Media Player is required to listen to the broadcast. Replay: An archived replay will be available for 30 days at https://www.gud-knight.com About Knight Therapeutics Inc. Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing innovative pharmaceutical products for Canada and Latin America. Knight owns Biotoscana Investments S.A., a pan-Latin American specialty pharmaceutical company. Knight Therapeutics Inc.'s shares trade on TSX under the symbol GUD. For more information about Knight Therapeutics Inc., please visit the company's web site at www.gud-knight.com or www.sedar.com. Forward-Looking Statement This document contains forward-looking statements for Knight Therapeutics Inc. and its subsidiaries. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. Knight Therapeutics Inc. considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared but cautions the reader that these assumptions regarding future events, many of which are beyond the control of Knight Therapeutics Inc. and its subsidiaries, may ultimately prove to be incorrect. Factors and risks, which could cause actual results to differ materially from current expectations are discussed in Knight Therapeutics Inc.'s Annual Report and in Knight Therapeutics Inc.'s Annual Information Form for the year ended December 31, 2020 as filed on www.sedar.com. Knight Therapeutics Inc. disclaims any intention or obligation to update or revise any forward-looking statements whether because of new information or future events, except as required by law. Investor Contact: Knight Therapeutics Inc.Samira SakhiaPresident and Chief Operating OfficerT: 514-484-4483F: email@example.com www.gud-knight.comArvind UtchanahChief Financial OfficerT: 514-484-4483F: firstname.lastname@example.org www.gud-knight.com
The new service quickly lapped up new subscribers and saw a sharp spike in daily orders in the space of just a few months, indicating that it would pose a significant challenge to Amazon's (NASDAQ: AMZN) ambition of dominating India's online grocery market. It now appears that JioMart has already made a big dent and is close on Amazon's heels in online groceries. Let's look at the recent developments that make JioMart a big headache for Amazon in India.
MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today that the Company's subordinate voting shares have been approved for listing on The Nasdaq Capital Market ("Nasdaq"). Trading is expected to begin on Tuesday, April 27, 2021, under the symbol "MNMD" on the Nasdaq. MindMed will retain its listing on the Neo Exchange Inc. under the symbol "MMED" and the Company's subordinate voting shares will continue to trade on the OTCQB under the symbol "MMEDF" until trading on the Nasdaq commences.
We spoke to Remdesivir’s parent company Gilead Sciences and found that the drug is not named after an Indian.
All Fayette County students will get free school meals in 2021-2022 due to the pandemic and when charges resume, the district will stop penalizing kids who have unpaid bills by offering only a cheese sandwich.
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Microcrystalline Cellulose (MCC) Market Size, Share And Industry Analysis, By Source Type (Non-Wood Based, Wood-Based), By End-Use (Binder/Diluent, Bulking Agent, Emulsifiers, Stabilizer, Anti-Caking Agent, Others), By Application (Pharmaceutical, Food & Beverage, Cosmetics & Per" report has been added to ResearchAndMarkets.com's offering. Increasing consumption of paints and coatings in various industries, growing use of the product as additive in food products are key factors driving market revenue growth.Market Size - USD 985.2 Million in 2020, Market Growth - CAGR of 5.8%, Market Trends - Rising investments in R&D and innovative products by players.The global microcrystalline cellulose (MCC) market size is expected to reach USD 1,561.4 Million in 2028, and register a CAGR of 5.8% during the forecast period. Market growth is driven by major factors such as growing consumption of processed foods by consumers, increasing sales of cosmetics and personal care products, as well as pharmaceuticals.In the pharmaceutical industry, MCC can be used for forming tablets from dry powder, and the mostly used in forming vitamin supplements. Growing number of health-conscious individuals, and spreading awareness regarding health-benefits of consuming microcrystalline cellulose are factors boosting market growth.Fluctuating costs of raw material, and availability of cost-effective substitutes are factors that could hamper market growth to a certain extent.Some Key Findings From the Report: Among the source type segments, the wood-based segment accounted for the largest revenue share in the global microcrystalline cellulose (MCC) market in 2020. The non-wood based segment is expected to register the highest revenue growth rate during the forecast period.Among the end-use segments, the binder/diluent segment accounted for the largest revenue share in the global microcrystalline cellulose (MCC) market in 2020. The bulking agent segment is expected to register the highest revenue growth rate during the forecast period.Among the application segments, the food and beverage segment is expected to register the highest revenue growth rate during the forecast period.Europe microcrystalline cellulose (MCC) market accounted for major share in terms of revenue in 2020, and is expected to continue with its dominance over the forecast period.Companies profiled in the market report include Rayonier Advanced Materials, Dowdupont, Asahi Kasei Chemicals Corporation, JRS Pharma GmbH & Co. Kg, Roquette, DFE Pharma GmbH & Co.Kg, Sigachi Industrial Pvt. Ltd., Avantor Performance Materials Inc., Gujarat Microwax Limited, and Huzhou City Linghu Xinwang Chemical Co., Ltd. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint. Reasons to Buy the Report A robust analysis and estimation of the Microcrystalline Cellulose (MCC) Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysisA holistic competitive landscape of the all the major players in Microcrystalline Cellulose (MCC) Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developmentsGo-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendorsMost deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamicsSpecial focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization Key Topics Covered: Chapter 1. Market Synopsis1.1. Market Definition1.2. Research Scope & Premise1.3. Methodology1.4. Market Estimation TechnologyChapter 2. Executive Summary 2.1. Summary Snapshot, 2020 - 2028Chapter 3. Indicative Metrics Chapter 4. Microcrystalline Cellulose (MCC) Market Segmentation & Impact Analysis 4.1. Microcrystalline Cellulose (MCC) Market Segmentation Analysis4.2. Industrial Outlook4.2.1. Market indicators analysis4.2.2. Market drivers analysis188.8.131.52. The rising use of MCC as a pharmaceutical excipient184.108.40.206. The expansion of the pharmaceutical sector220.127.116.11. The growth of the processed food sector18.104.22.168. The elevated demand for non-wood-based MCC4.2.3. Market restraints analysis22.214.171.124. Production of low-cost MCC126.96.36.199. Presence of substitutes for particular food & beverages applications4.3. Technological Insights4.4. Regulatory Framework4.5. ETOP Analysis4.6. Porter's Five Forces Analysis4.7. Competitive Metric Space Analysis4.8. Price Trend AnalysisChapter 5. Microcrystalline Cellulose (MCC) Market By Source Type Insights & Trends 5.1. Source Type Dynamics & Market Share, 2021 & 20285.2. Non-Wood Based5.2.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)5.2.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)5.3. Wood-Based5.3.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)5.3.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)Chapter 6. Microcrystalline Cellulose (MCC) Market By End-use Insights & Trends 6.1. End-use Dynamics & Market Share, 2021 & 20286.2. Binder/Diluent6.2.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)6.2.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)6.3. Bulking agent6.3.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)6.3.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)6.4. Emulsifiers6.4.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)6.4.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)6.5. Stabilizer6.5.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)6.5.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)6.6. Anti-Caking Agent6.6.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)6.6.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)6.7. Others6.7.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)6.7.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)Chapter 7. Microcrystalline Cellulose (MCC) Market By Application Insights & Trends 7.1. Application Dynamics & Market Share, 2021 & 20287.2. Pharmaceutical7.2.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)7.2.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)7.3. Food & Beverage7.3.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)7.3.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)7.4. Cosmetics & Personal Care7.4.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)7.4.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)7.5. Paints & coatings7.5.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)7.5.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)7.6. Others7.6.1. Market estimates and forecast, 2018 - 2028 (USD Million) (Kilo Tons)7.6.2. Market estimates and forecast, By Region, 2018 - 2028 (USD Million) (Kilo Tons)Chapter 8. Microcrystalline Cellulose (MCC) Market Regional Outlook 8.1. Microcrystalline Cellulose (MCC) Market share By Region, 2021 & 20288.2. North America8.3. Europe8.4. Asia-Pacific8.5. Middle East and Africa8.6. Latin AmericaChapter 9. Competitive Landscape 9.1. Market Revenue Share By Manufacturers9.2. Manufacturing Cost Breakdown Analysis9.3. Mergers & Acquisitions9.4. Market positioning9.5. Strategy Benchmarking9.6. Vendor LandscapeChapter 10. Company Profiles 10.1. Rayonier Advanced Materials10.1.1. Company Overview10.1.2. Financial Performance10.1.3. Technology Insights10.1.4. Strategic Initiatives10.2. Dowdupont10.2.1. Company Overview10.2.2. Financial Performance10.2.3. Technology Insights10.2.4. Strategic Initiatives10.3. Asahi Kasei Chemicals Corporation10.3.1. Company Overview10.3.2. Financial Performance10.3.3. Technology Insights10.3.4. Strategic Initiatives10.4. JRS Pharma GmbH & Co. Kg10.4.1. Company Overview10.4.2. Financial Performance10.4.3. Technology Insights10.4.4. Strategic Initiatives10.5. Roquette10.5.1. Company Overview10.5.2. Financial Performance10.5.3. Technology Insights10.5.4. Strategic Initiatives10.6. DFE Pharma GmbH & Co. Kg10.6.1. Company Overview10.6.2. Financial Performance10.6.3. Technology Insights10.6.4. Strategic Initiatives10.7. Sigachi Industrial Pvt. Ltd.10.7.1. Company Overview10.7.2. Financial Performance10.7.3. Technology Insights10.7.4. Strategic Initiatives10.8. Avantor Performance Materials, Inc.10.8.1. Company Overview10.8.2. Financial Performance10.8.3. Technology Insights10.8.4. Strategic Initiatives10.9. Gujarat Microwax Limited10.9.1. Company Overview10.9.2. Financial Performance10.9.3. Technology Insights10.9.4. Strategic Initiatives10.10. Huzhou City Linghu Xinwang Chemical Co., Ltd10.10.1. Company Overview10.10.2. Financial Performance10.10.3. Technology Insights10.10.4. Strategic InitiativesFor more information about this report visit https://www.researchandmarkets.com/r/75bg2r CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Claire Griffith says her 'insides are a mass of adhesions and mesh' after rectopexy operation.
Today’s headlines: CD Projekt Red made hundreds of millions on 'Cyberpunk 2077' made hundreds of millions despite the refunds, Signal hacked some Cellebrite’s phone hacking software used by law enforcement and the next version of iOS may revamp notifications.
Atlanta loses the top spot after 22 consecutive years
From Riz Ahmed becoming the first Muslim nominated for best actor, to Chloé Zhao's nomination as the first woman of colour in the directing category, this year’s eclectic mix practically ensures Oscar history will be made.
The decisions were taken by UEFA’s executive committee following a meeting on Friday morning.